The National Human Genome Research Institute (NHGRI) has awarded a $29,276 firm fixed-price purchase order to Eminent Services Corp for refrigerated transport and storage of investigational drugs, with an ultimate completion date of August 31, 2026. This new award, announced on September 3, 2025, represents a non-set-aside procurement open to all qualified contractors. The contract requires specialized cold chain logistics capabilities to maintain temperature-sensitive pharmaceutical products in compliance with regulatory standards, a service area in which Eminent Services Corp has demonstrated prior experience through its recent pharmaceutical support work with NHGRI.
Eminent Services Corp, a minority-owned business based in Frederick, Maryland, brings relevant qualifications to this engagement through its established focus on pharmaceutical, biological, and information technology services for the federal government and biotechnology sector. The company has previously supported NHGRI operations, having secured a $14,626 package and delivery services contract in 2024, and has maintained a stable collaborative relationship with the University of South Florida as a sub-grantee supporting medical research initiatives. This award positions the contractor to provide critical logistical support for investigational drug handling, a specialized function essential to the Institute's research operations in Bethesda, Maryland.